Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2012

Jul 30, 2012

29777_dirs_2012-07-30_ba4d31ad-5c87-47a6-aff0-9d462009d339.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-07-27

Reporting Person: ALBAN CARLOS (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-07-27 Common shares without par value M 7299 $46.34 Acquired 122468 Direct
2012-07-27 Common shares without par value M 5200 $44.16 Acquired 127668 Direct
2012-07-27 Common shares without par value M 30800 $41.48 Acquired 158468 Direct
2012-07-27 Common shares without par value M 1538 $56.98 Acquired 160006 Direct
2012-07-27 Common shares without par value S 43299 $65.00 Disposed 116707 Direct
2012-07-27 Common shares without par value S 1538 $66.00 Disposed 115169 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-07-27 Option (right to buy) $46.34 M 7299 Disposed 2015-02-17 Common shares (7299) Direct
2012-07-27 Option (right to buy) $44.16 M 5200 Disposed 2016-02-16 Common shares (5200) Direct
2012-07-27 Option (right to buy) $41.48 M 30800 Disposed 2016-04-23 Common shares (30800) Direct
2012-07-27 Option (right to buy) $56.98 M 1538 Disposed 2013-02-13 Common shares (1538) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.